In conclusion, our data indicate that IL-4/IL-13-stimulated MoMF have restorative functions, but their quantity could be insufficient to cope with the worsening of chronic inflammation in late-stage NASH. The gene discussed is IL13; the disease is metabolic dysfunction-associated steatohepatitis.